De un laboratorio en Mayagüez al mercado farmacéutico global

CienciaPR

By -

De izquierda a derecha: Josiah Hernández, Dr. Carlos Conde y Dr. Rodolfo Romañach durante un panel sobre transferencia tecnológica.

From a Lab in Mayagüez to the Global Pharmaceutical Market

Technology developed over 26 years by a UPRM researcher is licensed by a Puerto Rican company and has already been acquired by two international pharmaceutical companies.

San Juan, Puerto Rico. September 8, 2026. A technology developed over 26 years by a researcher at the University of Puerto Rico at Mayagüez (UPRM), Dr. Rodolfo Romañach, has now reached the international pharmaceutical market through a Puerto Rican company.

The technology is the Stream Sampling Kit (SSK), licensed by CIS International LLC, a Puerto Rican company with more than 15 years of experience in the pharmaceutical and biotechnology industries. The technology has already been acquired by two international pharmaceutical companies, whose teams are currently in the process of installing the equipment at their facilities.

The licensing process was supported by the Technology Transfer Office (TTO) of the Fideicomiso para Ciencia, Tecnología e Investigación de Puerto Rico (PRSTRT), which facilitated the documentation, managed the intellectual property, and coordinated each step in the correct order to connect university research with the market. This case demonstrates how an innovation developed in Puerto Rico can move from the lab to become a solution used by companies with global reach.

 

A Technology to Improve Medication Quality Control

Many of the tablets and capsules we use contain an active ingredient mixed with other components known as excipients. For each tablet or capsule to contain the correct amount of active ingredient, the mixture must be uniform.

The Stream Sampling Kit allows samples of that powder mixture to be taken during the production process to verify its uniformity, without stopping the process or altering the mixture.

Unlike traditional methods, which may be limited to about 30 samples in a production run of approximately 300 kilograms, the SSK can obtain thousands of samples without affecting the product. This allows manufacturers to gain more insight into what's happening during the process and detect possible variations with greater precision.

The technology can be used in the production of tablets and capsules that require powder mixtures, and can help reduce interruptions, waste, and reprocessing, while also supporting compliance with pharmaceutical industry quality standards.

"The order in which you do things is essential. The Fideicomiso's TTO guided us to do everything in the right order," said Dr. Rodolfo Romañach, researcher at the University of Puerto Rico at Mayagüez.

From Research to Industry

Bringing a technology from the lab to the market requires protecting intellectual property, identifying opportunities, and connecting research with companies that can develop and commercialize it.

In this case, CIS International LLC took on the process of bringing the SSK to market, drawing on its experience in the pharmaceutical, biotechnology, medical device, and food and beverage sectors, with operations in Puerto Rico, the United States, and international markets.

"We managed to make our first sale to a pharmaceutical company in the Chicago area, in the United States. That's why we're extremely happy — not just my company, but because this also impacts Puerto Rico and can motivate other scientists and entrepreneurs to license technologies like this one," said Dr. Carlos Conde, CEO of CIS International LLC.

The process was supported by the Fideicomiso's TTO, which works with researchers to protect their discoveries, identify commercialization opportunities, and facilitate licensing agreements with companies and strategic partners.

"This is exactly why the TTO exists. Researchers like Dr. Romañach, entrepreneurs like Dr. Conde, and the right institutional support, in the right order, can turn innovation into impact," said Josiah Hernández, technology manager at the Technology Transfer Office of the Fideicomiso para Ciencia, Tecnología e Investigación de Puerto Rico.

The TTO currently maintains a portfolio of more than 70 technologies available for licensing and supports the protection of 183 active patents related to research developed in Puerto Rico.

The office works alongside researchers and academic institutions to identify technologies with scientific and commercial potential, protect their intellectual property, connect researchers with companies and entrepreneurs, and facilitate licensing and technology transfer agreements.

The Stream Sampling Kit case demonstrates how scientific research discoveries in Puerto Rico can be transformed into intellectual property, create opportunities for local companies, and reach international market

About the Fideicomiso para Ciencia, Tecnología e Investigación:

The Fideicomiso para Ciencia, Tecnología e Investigación de Puerto Rico, as described in Public Law 214-204, as amended, is a private, nonprofit organization created in 2004 to drive the Island's participation and job creation in the global knowledge economy by promoting investment in, and funding for, research and development in science and technology. It invests in, facilitates, and develops the capabilities that continuously advance Puerto Rico's economy and the well-being of its citizens, through research and development-based ventures, science and technology, public health, and innovation—with the goal of making Puerto Rico a globally recognized hub of innovation. The Fideicomiso para Ciencia, Tecnología e Investigación de Puerto Rico was also designated one of 31 Tech Hubs in 2023, to lead the PRBio Tech Hub, in partnership with a multisector consortium on the Island. For more information: www.prsciencetrust.org.

Content Categories
Categories (Educational Resources)
English
No votes yet